BG1805

BIOLOGICAL2 trials

Sponsors

Guangzhou Bio-gene Technology Co., Ltd

Conditions

Acute Myeloid LeukemiaLeukemiaLeukemia, Myeloid, Acute

Phase 1

Phase I Clinical Study: BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

RecruitingNCT06118788

Guangzhou Bio-gene Technology Co., LtdLeukemia, Myeloid, Acute

Start: 2024-03-07End: 2027-07-31Target: 24Updated: 2025-04-17

BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia in Children

Not yet recruitingNCT06347458

Guangzhou Bio-gene Technology Co., LtdAcute Myeloid Leukemia, Leukemia

Start: 2024-04-30End: 2027-08-31Target: 24Updated: 2024-04-04